calendar
28,902 catalysts · 9,622 approval · 5,000 device 510k · 4,728 grant · 2,761 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
28,902 catalysts · 9,622 approval · 5,000 device 510k · 4,728 grant · 2,761 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: RISING. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Sponsor: ALKEM LABS LTD. Form: SOLUTION. Route: ORAL
Sponsor: ENDO OPERATIONS. Form: IMPLANT. Route: SUBCUTANEOUS
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: SANOFI-AVENTIS US. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: JANSSEN PHARMS. Form: SPRAY. Route: NASAL
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION
Sponsor: ALKEM LABS LTD. Form: CAPSULE. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: SUPERNUS PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: SCHERING. Form: SUSPENSION. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: SUSPENSION. Route: ORAL
Sponsor: GRANULES INDIA. Form: TABLET. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: UCB INC. Form: INJECTABLE. Route: INJECTION
Sponsor: BARR LABS INC. Form: TABLET. Route: ORAL
Sponsor: SANOFI AVENTIS US. Form: INJECTABLE. Route: INJECTION
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: SANOFI AVENTIS US. Form: CAPSULE. Route: ORAL
Sponsor: CUBIST PHARMS LLC. Form: TABLET. Route: ORAL
Sponsor: CUBIST PHARMS LLC. Form: POWDER. Route: INTRAVENOUS
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: WES PHARMA INC. Form: SOLUTION. Route: ORAL
Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION
Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: SCHERING. Form: SUSPENSION. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: INGENUS PHARMS LLC. Form: CAPSULE. Route: ORAL
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: INJECTION
Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET. Route: ORAL
Sponsor: UCB INC. Form: INJECTABLE. Route: INJECTION
Sponsor: SPROUT PHARMS. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS. Form: INJECTABLE. Route: INJECTION
Sponsor: ACTAVIS. Form: INJECTABLE. Route: INJECTION